<description>&lt;p&gt;Interview with Allison W. Willis, MD, MS, author of Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events. Hosted by Cynthia E. Armand, MD.&lt;br /&gt; &lt;br /&gt; &lt;strong&gt;Related Content:&lt;/strong&gt;&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a class="related-article" href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2024.2057?utm_source=podcast_platforms&amp;utm_medium=referral&amp;utm_campaign=related_article_links" target="_blank" rel="noopener"&gt;Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt;</description>

JAMA Neurology Author Interviews

JAMA Network

Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events

JUL 8, 202419 MIN
JAMA Neurology Author Interviews

Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events

JUL 8, 202419 MIN

Description

Interview with Allison W. Willis, MD, MS, author of Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events. Hosted by Cynthia E. Armand, MD. Related Content: